CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Free Cash Flow Growth by Quarter and Year

Merck And Co Inc 's Free Cash Flow results by quarter and year




MRK Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 4,006.00 4,794.00 3,592.00
III Quarter September - 2,173.00 4,226.00 2,793.00
II Quarter June - 3,367.00 3,084.00 3,382.00
I Quarter March 1,791.00 707.00 1,336.00 1,155.00
FY   1,791.00 10,253.00 13,440.00 10,922.00



MRK Free Cash Flow first quarter 2021 Y/Y Growth Comment
Merck and Co Inc achieved in the first quarter, above Company average Free Cash Flow surge of 153.32% year on year, to $ 1,791.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 12 other companies have achieved higher Free Cash Flow growth. While Merck And Co Inc ' s Free Cash Flow doubling of 153.32% ranks overall at the positon no. 562 in the first quarter.




MRK Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -16.44 % 33.46 % -10.54 %
III Quarter September - -48.58 % 51.31 % -
II Quarter June - 9.18 % -8.81 % 1.96 %
I Quarter March 153.32 % -47.08 % 15.67 % 303.85 %
FY   - -23.71 % 23.05 % 69.41 %

Financial Statements
Merck And Co Inc 's first quarter 2021 Free Cash Flow $ 1,791.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2020 Free Cash Flow $ 707.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Free Cash Flow Growth >>


MRK Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 84.35 % 13.44 % 28.61 %
III Quarter September - -35.46 % 37.03 % -17.42 %
II Quarter June - 376.24 % 130.84 % 192.81 %
I Quarter March -55.29 % -85.25 % -62.81 % -71.23 %
FY (Year on Year)   - -23.71 % 23.05 % 69.41 %




Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #52
Overall #562

Free Cash Flow Y/Y Growth Statistics
High Average Low
83.46 % 3.5 % -48.73 %
(Sep. 30, 2010)   (Dec. 30, 2009)
Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #52
Overall #562
Free Cash Flow Y/Y Growth Statistics
High Average Low
83.46 % 3.5 % -48.73 %
(Sep. 30, 2010)   (Dec. 30, 2009)

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Merck And Co Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
1059.79 % 58.25 % -100 %
(Jun 30 2017)  


MRK's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Merck And Co Inc realized fall in Free Cash Flow from the forth quarter by -55.29% to $ 1,791.00 millions, from $ 4,006.00 millions released a quarter before.

But that's not important issue, as Merck And Co Inc 's Free Cash Flow always tend to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 23 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Merck And Co Inc 's Free Cash Flow growth quarter on quarter, overall rank is 885.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #72
Overall #885
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #72
Overall #885
Free Cash Flow Q/Q Growth Statistics
High Average Low
1059.79 % 58.25 % -100 %
(Jun 30 2017)  


MRK's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Merck And Co Inc realized fall in Free Cash Flow from the forth quarter by -55.29% to $ 1,791.00 millions, from $ 4,006.00 millions declared in the previous quarter.

If you analyse current downturn in the quarter, you must presume, that commonly I. Quarter Free Cash Flow appear to be sluggish in contrast to the forth quarter, Richard Anderson, Healthcare sector contributor based in Boston added.

Within Major Pharmaceutical Preparations industry 23 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Merck And Co Inc 's Free Cash Flow growth quarter on quarter, overall rank is 885.


Merck And Co Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Free Cash Flow 12 Months Ending $ 16,169.00 $ 14,937.00 $ 15,348.00 $ 16,844.00 $ 16,675.00
Y / Y Free Cash Flow Growth (TTM) -3.03 % -11.68 % -1 % 22.38 % 20.28 %
Year on Year Free Cash Flow Growth Overall Ranking # 850 # 951 # 1399 # 405 # 452
Seqeuential Free Cash Flow Change (TTM) 8.25 % -2.68 % -8.88 % 1.01 % -1.41 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 562 # 1535 # 1891 # 617 # 1422




Cumulative Free Cash Flow growth Comment
Merck And Co Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Merck And Co Inc 's annual Free Cash Flow decline would be -3.03% year on year to $16,169 millions.

In the Healthcare sector 82 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 850, from total ranking in previous quarter at 951.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
83.46 %
3.5 %
-48.73 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 83
Overall # 850

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
481.43 %
23.61 %
-77.14 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 52
S&P 500 # 562
Cumulative Free Cash Flow growth Comment
Merck And Co Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Merck And Co Inc 's annual Free Cash Flow drop would be -3.03% year on year to $16,169 millions.

In the Healthcare sector 82 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 850, from total ranking in previous quarter at 951.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
83.46 %
3.5 %
-48.73 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 83
Overall # 850

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
481.43 %
23.61 %
-77.14 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 52
S&P 500 # 562




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
MRK's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for MRK's Competitors
Free Cash Flow Growth for Merck And Co Inc 's Suppliers
Free Cash Flow Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Free Cash Flow drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2021
Msa Safety Inc235.24%$ 235.239 millions
Integra Lifesciences Holdings Corp231.90%$ 231.897 millions
Pra Health Sciences Inc 217.26%$ 217.264 millions
Amneal Pharmaceuticals Inc 202.14%$ 202.142 millions
Quest Diagnostics Inc195.95%$ 195.951 millions
Mallinckrodt Plc181.94%$ 181.937 millions
Five Star Senior Living Inc 173.87%$ 173.874 millions
National Research Corporation160.87%$ 160.873 millions
Merck and Co Inc 153.32%$ 153.324 millions
Charles River Laboratories International inc 148.18%$ 148.183 millions
Becton Dickinson And Company145.96%$ 145.963 millions
Neurocrine Biosciences Inc 128.53%$ 128.534 millions
Hill rom Holdings Inc 123.96%$ 123.965 millions
Vericel Corporation115.24%$ 115.237 millions
Pacira Biosciences inc 94.60%$ 94.604 millions
Gilead Sciences Inc 81.75%$ 81.755 millions
Bio rad Laboratories Inc 80.88%$ 80.885 millions
Community Health Systems Inc 77.19%$ 77.193 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SLGN's Profile

Stock Price

SLGN's Financials

Business Description

Fundamentals

Charts & Quotes

SLGN's News

Suppliers

SLGN's Competitors

Customers & Markets

Economic Indicators

SLGN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071